HIGHLIGHTS
- who: VIROLOGY and collaborators from the of Vaccines and Serums and Bacterial Preparations Production Company of the FMBA of Russia have published the Article: EVALUATION METHODS AVIAN LEUCOSIS VIRUS INACTIVATION IN PRODUCTION, in the Journal: (JOURNAL)
- what: The aim of this study was to select an optimal agent to inactivate the contaminant of influenza vaccines, avian leucosis virus, its most common groups RAV-1 (subgroup A) and RAV-2 (subgroup B) in particular. This study has shown that the minimum time of inactivation of the allantoic fluid containing the avian leucosis virus with u03b2-propiolactone . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.